Lupin Reports High ESG Score In Latest Assessment
Lupin reports a marked rise in its S&P Global environmental, social and governance score, which now stands at 91, well above the pharmaceutical industry average Lupin has received an S&P Global environmental, social and governance score of 91 for 2025, placing it among a small group of companies worldwide that have crossed the 90-point mark. […]



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































